Company intelligence / Profile preview

IMACA

Utrecht, Utrecht, Netherlands

Ownership: Private
Development stage: Other

Overview

Imaca (Imaging and Characterization) was a specialized contract research organization (CRO) that provided advanced medical imaging services for clinical trials. Founded as a spin-off from the University Medical Center Utrecht (UMC Utrecht) in the Netherlands, the company focused on the application of MRI, CT, and PET imaging in drug development. Imaca offered comprehensive imaging core lab services, including protocol design, image analysis, and data management for pharmaceutical and biotechnology companies. The company was particularly known for its expertise in musculoskeletal and cardiovascular imaging. In 2010, Imaca was acquired by BioClinica (now part of Clario) to enhance its global imaging capabilities.

Industry: Contract Research Organization

Beyond the preview

Go deeper on IMACA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IMACA.

Explore the full profile